Number of the records: 1
antagonisty dopamínu
SYS d018492 LBL 00000cz--a2200000n--4500 005 20250606214405.7 008 940601|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $a BA006 $a BA006 $d BA006 065 $a D27.505.519.625.150.175 065 $a D27.505.696.577.150.175 066 $a 01 $c 03 150 $a antagonisty dopamínu $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Dopamine Antagonist $2 eng 450 $w v $a Dopamine Blocker $2 eng 450 $w v $a Dopamine Receptor Antagonist $2 eng 450 $w v $a Dopamine Receptor Antagonists $2 eng 450 $w v $a Dopaminergic Antagonist $2 eng 450 $w v $a Dopaminergic Antagonists $2 eng 450 $w v $a antagonista dopamínových receptorov $2 slo 450 $w v $a antagonisty dopamínergické $2 slo 450 $w v $a blokátory dopamínu $2 slo 550 $7 sllk_us_auth*d014150 $Y Antipsychotic Agents $w b $a antipsychotiká 665 $a 95 $2 eng 665 $a Dopamine/antagonists & inhibitors (1966-1994) $2 eng 680 9-
$i Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. $2 eng 750 -2
$a Dopamine Antagonists $2 eng 980 $x M
Number of the records: 1